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Although extensive studies provided molecular and pharmacological characterization of metabotropic P2Y receptors for extracellular
nucleotides, little is still known about their quaternary structure. By the use of transfected cellular systems and SDS-PAGE, in our previous work we
established the propensity of P2Y4 receptor to form dimeric interactions. Here we focused on endogenously expressed P2Y4 and P2Y6 subtypes,
comparing their oligomeric complexes under Blue Native (BN) gel electrophoresis. We provided evidence that P2Y4 and P2Y6 receptors form high
order complexes in native neuronal phenotypes and that the oligomers can be disaggregated down to the dimeric P2Y4 or to the dimeric and
monomeric P2Y6 receptor. Moreover, dimeric P2Y4 and monomeric P2Y6 proteins display selective microdomain partitioning in lipid rafts from
specialized subcellular compartments such as synaptosomes. Ligand activation by UTP shifted the oligomerization of P2Y6 but not of P2Y4
receptor, as analysed by BN electrophoresis. Finally, whereas transfected P2Y4 and P2Y6 proteins homo-interact and posses the appropriate
domains to associate with all P2Y1,2,4,6,11 subtypes, in naive PC12 cells the endogenous P2Y4 forms hetero-oligomers only with the P2Y6 subunit.
In conclusion, our results indicate that quaternary structure distinguishing P2Y4 from P2Y6 receptors might be crucial for specific ligand activation,
membrane partitioning and consequent functional regulation.
© 2007 Elsevier B.V. All rights reserved.Keywords: GPCR; Purinergic receptor; Dimerization; Lipid raft; Synaptosomes1. Introduction
Whereas G protein-coupled receptors (GPCRs) have been
depicted for a long time as monomeric subunits interacting with
hetero-trimeric G proteins upon ligand activation, more recently
this vision was unsettled by a growing body of biochemical and
biophysical evidence indicating that the propensity to form
homo- and hetero-dimers is widespread also in the GPCR
family [1–3]. Several studies mainly performed with recombi-
nant proteins have indeed shown that dimerization occurs earlyAbbreviations: BN, Blue Native; DM, N-dodecyl-β-maltoside; DTT,
dithiothreitol; FCS, foetal calf serum; GPCRs, G protein-coupled receptors;
HDAC, histone deacetylase; PAGE, polyacrylamide gel electrophoresis; SDS,
sodium dodecyl sulphate; SNAP, synaptosome-associated protein
⁎ Corresponding author. Tel.: +3906 501703084; fax: +3906 501703321.
E-mail address: n.dambrosi@hsantalucia.it (N. D’Ambrosi).
0005-2736/$ - see front matter © 2007 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamem.2007.03.020after receptor biosynthesis, suggesting either a primary role in
receptor maturation and transport to the plasma membrane, or a
more general requisite for function [4].
P2Y metabotropic receptors, widely distributed in the
central and peripheral nervous system and involved in various
functions ranging from neurotransmission and neuromodula-
tion to trophic and toxic actions [5], belong to the superfamily
of GPCRs. They are categorized into a subfamily that predo-
minantly couple to Gq protein and activate phospholipase C-β
(P2Y1, P2Y2, P2Y4, P2Y6 and P2Y11 receptor), and into a
subfamily of Gi protein-coupled receptors that inhibit adenylyl
cyclase and regulate ion channels (P2Y12, P2Y13 and P2Y14
receptors) [6]. Although extensive studies provided molecular
and pharmacological characterization of P2Y GPCRs [7], little
is still known particularly about their quaternary structure. On
this subject, recent studies demonstrated that the P2Y1 subunit
forms constitutive and agonist-promoted hetero-complexes
with adenosine A1 receptor, as shown by co-immunoprecipita-
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fected cells and in rat brain [8–10]. Moreover, it was de-
monstrated by fluorescence energy transfer measurements that
the transfected P2Y2 receptor forms oligomers [11], and that the
active metabolite of the antagonist Clopidogrel specific for the
P2Y12 receptor can modulate protein oligomerization in plate-
lets in vivo and in full-length P2Y12-expressing HEK cells
[12].
By the use of transfected cellular systems and sodium
dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-
PAGE), in our previous work we established the propensity of
P2Y4 receptor to form dimeric complexes partially sensitive to
reducing agents [13]. Since caveats must be generally placed on
the analysis of immunoprecipitation studies using transfected
proteins, in the present work we focused our analysis on
endogenously expressed GPCRs, evaluating the quaternary
structure particularly of native P2Y4 and P2Y6 subtypes. This
choice was justified by the notion that, within the same
subfamily of Gq-coupled P2Y proteins, these two receptors
display 40% aminoacid homology [14], are expressed at com-
parably moderate levels in the central nervous system [15], and
are specifically activated by pyrimidine nucleotides [7]. Never-
theless, they are differently regulated by agonists, desensitised
and recycled at the plasma membrane [16]. With our present
work, we highlighted additional differences between these two
receptors, and provided biochemical evidence that whereas they
both can form high order homo- and/or hetero-oligomers, the
protomeric unit at the basis of each complex appeared to be the
monomer with respect to the P2Y6 receptor, or the dimer for the
P2Y4 subtype. Moreover, the monomeric/dimeric protomers are
differently distributed in specialized membrane microdomains
such as lipid rafts from cerebellar synaptosomes, and the P2Y4
and P2Y6 oligomeric complexes are differently stabilized by
agonist activation.
In synthesis, our results represent a further step in the mole-
cular knowledge of GPCRs and particularly of P2Y4 and P2Y6
receptors, prospecting novel pharmacological and functional
consequences related to their complex oligomerization.2. Materials and methods
2.1. Cell lines and pharmacological treatments
Rat phaeochromocytoma PC12 cells were cultured on collagen-coated
dishes in RPMI 1640 medium (Gibco BRL, MI-Italy) supplemented with 10%
heat inactivated horse serum and 5% foetal calf serum (FCS) (Gibco BRL);
human neuroblastoma SH-SY5Y cells were maintained in DMEM/F12 medium
(Sigma-Aldrich, MI, Italy), added with 10% FCS. All culture media were
supplemented with glutamine (2 mM), penicillin (50 units/ml), and streptomycin
(50 μg/ml) and all cell lines were grown at 37 °C in 5% CO2. For ligand
stimulation experiments, 100 μM UTP (Sigma-Aldrich) was directly added to
cells in complete culture media, for the indicated times.
2.2. Construction of epitope-tagged human P2Y receptors and
transient transfections
Myc- and FLAG-P2Y4 plasmids were obtained as previously described [13].
cDNAs encoding for P2Y1, P2Y2, P2Y6 and P2Y11 were digested with EcoRI
and XhoI restriction enzymes and ligated into a pCMV expression vector thatincorporated a FLAG epitope tag (DYKDDDDK) at the 5′ terminus. In addition,
by the use of polymerase chain reaction with Platinum® Pfx polymerase (Invi-
trogen, Paisley, UK), all cDNAs were also amplified with appropriate oligo-
nucleotides containing EcoRI and XhoI restriction sequences for the subcloning
of each DNA into a pCS2 plasmid with a c-Myc epitope tag at the 5′ terminus.
All constructs were verified by sequencing analysis. SH-SY5Y cells were
transiently transfected with P2Y receptor cDNAs individually or in pairs using
Lipofectamine™ 2000 (Invitrogen), according to the manufacturer's instruc-
tions, in serum-free medium (Opti-MEM, Invitrogen) for 24 h. Control cells
(mocks) were transfected with the empty pCMVor pCS2 vectors.
2.3. Protein extraction
In order to isolate total protein extracts, cells were harvested with either ice-
cold RIPA buffer (PBS, 1% Nonidet P-40—NP-40-, 0.5% sodium deoxy-
cholate, 0.1% sodium dodecyl sulphate—SDS-), or an hypotonic buffer com-
posed of 20 mM Tris–HCl, pH 7.4, 10 mM NaCl, in the absence or presence of
1% Triton-X 100, 1% N-dodecyl-β-maltoside (DM) or 0.1 to 1% digitonin. For
Blue Native (BN) gels, cells were lysed in BN-lysis buffer (50 mM Bis-Tris, pH
7, 1% DM, 10% glycerol, 0.75 M aminocaproic acid). Cells were also lysed in
buffer G (20 mM Tris, pH 7.4, 1% Triton X-100, 10% glycerol, 150 mM NaCl,
1.5 mMMgCl2, 1 mMCaCl2, 1 mM EGTA), in order to be immunoprecipitated.
All buffers were added with 1 mM phenylmethylsulphonyl fluoride (PMSF) and
10 μg/ml leupeptin. Cellular lysates were kept for 30 min on ice and then
centrifuged for 10 min at 14,000×g, at 4 °C. Supernatants were collected and
assayed for protein quantification by the Bradford method [17].
2.4. Immunoprecipitation
Cell lysates from tagged-receptor transfected cells were combined with 15 μl
(packed gel) of either anti-c-Myc or anti-FLAG M2 affinity agarose (Sigma-
Aldrich) and kept for 2 h at 4 °C on a rotator. Native P2Y2, P2Y4 and P2Y6
receptor in PC12 cells were immunoprecipitated with 2 μg of anti-P2Y2, anti-
P2Y4 or -P2Y6 antisera (Alomone Labs, Jerusalem, Israel) followed by incu-
bation with 25 μl (packed gel) of True Blot™ anti-rabbit IgG beads (eBioscience
Inc., San Diego, CA, USA). The immunoadsorbents were recovered by centri-
fugation for 2 min at 3000×g and washed three times by resuspension–
centrifugation for 2 min at 3000×g in buffer G. The samples were eluted in 30 μl
of 2× sample buffer used for SDS- PAGE.
2.5. Synaptosome Triton X-100 solubilization and sucrose floatation
gradients
Synaptosomes were obtained from rat cerebella by means of differential
centrifugation, essentially as previously described [18]. Briefly, post-nuclear
supernatants were centrifuged at 9200×g for 15 min to yield a pellet corres-
ponding to partially purified synaptosomes. These pellets (6 mg of proteins)
were resuspended in 750 μl of buffer A (150 mM NaCl, 2 mM EGTA, 50 mM
Tris–HCl, pH 7.5, protease inhibitors) containing 1% (w/v) Triton X-100. After
30 min on ice, each sample was adjusted to 1.2 M sucrose, placed in a centrifuge
tube and overlaid with a linear gradient ranging from 30% to 5% sucrose (all
prepared in buffer A). The gradients were centrifuged at 190,000×g for 19 h
using a rotor SW 41 Ti (Beckman Instruments, Inc., CA, and USA). Fifteen
fractions (800 μl each), and the pellets resuspended in 800 μl of buffer A were
collected and analysed by means of SDS-PAGE and western blotting. The
sucrose concentration in each fraction was determined by refractometry.
2.6. SDS-, BN-PAGE and western blot analysis
Analysis of denatured protein components was performed on 10% poly-
acrylamide gels and transferred onto nitrocellulose membranes (Amersham
Biosciences, Cologno Monzese, Italy). BN-PAGE was carried out essentially as
described [19]: total proteins (in native form or incubated for 1 h at 37 °C with
SDS from 0.1 to 2%) were run on 8–16% gradient or 8% or 12% linear gels and
blotted on PVDF membranes (Amersham Biosciences). In all cases, after
saturation blots were probed overnight at 4 °C, with anti-P2Y4 or anti P2Y6
antisera (Alomone Labs) used 1:300 (specificity tested by immunoreactions
Fig. 1. Presence of oligomeric forms of P2Y4 and P2Y6 receptor in both BN- and
SDS-PAGE conditions. Total protein from PC12 and SH-SY5Y cells were lysed
with BN-lysis buffer or RIPA buffer. Samples processed for native electrophor-
esis were run on 8–16% gels in the absence or presence of 0.1% SDS (A) or 12%
gels with or without 1% SDS (B) and blotted onto PVDF filters. Proteins sub-
jected to SDS-PAGE were run on 10% polyacrylamide gel and transferred onto
nitrocellulose membranes. Filters were then probed with anti-P2Y4 (A) or anti-
P2Y6 (B) antiserum in the absence (−) or presence (+) of the antigen peptide.
Protein bands were detected by ECL chemiluminescence with secondary anti-
rabbit antiserum coupled to horseradish peroxidase. BN blots are representative
of three separate experiments, while SDS-PAGE blots are representative of at
least six independent experiments.
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and antiserum), anti-P2Y2, (1:300, Alomone Labs), anti c-Myc polyclonal anti-
serum (1:1000, Sigma Aldrich), anti c-Myc (9E10) monoclonal antibody (1:200,
Chemicon International Inc., Temecula, CA, USA), anti-flotillin-2/ESA
antibody (1:5000, BD Biosciences, San Jose, CA, USA), anti-transferrin re-
ceptor (1:1,000, Zymed Laboratories, San Francisco, CA, USA), anti-syntaxin1
(1:10000, Sigma Aldrich), anti-synaptobrevin/VAMP-2 (1:10000, Synaptic
Systems, Goettingen, Germany) and anti-synaptosome-associated protein
(SNAP)-25 (1:5000, Synaptic Systems) monoclonal antibodies. Subsequently,
blots were incubated for 1 h with horseradish peroxidase-coupled anti-rabbit
(1:5000) (Cell Signaling Technology, Inc., Beverly, MA, USA), with anti rabbit
IgG True Blot™ (1: 1000, eBiosciences Inc) in the case of Fig. 4, or anti-mouse
antibody (1:2500, Cell Signaling Technology, Inc.), and visualized using ECL
chemiluminescence (Amersham Biosciences). In order to detect ganglioside
GM1, aliquots of synaptosome sucrose-gradient fractions were spotted directly
onto nitrocellulose membranes, which were then probed with peroxidase-
coupled cholera toxin subunit B (1:100,000, Sigma-Aldrich, Milan, Italy).
Image analysis and quantifications were performed by Kodak Image Station
(KDS IS440CF 1.1) with 1D Image Analysis software.
3. Results
3.1. BN- and SDS-PAGE reveal complex levels of
oligomerization for endogenous P2Y4 and P2Y6 receptors in
neuronal systems
As a first approach to investigate native oligomerization and
quaternary structure of GPCRs we applied BN-PAGE technique
particularly to the study of P2Y4 and P2Y6 receptor proteins.
Under native conditions, endogenous P2Y4 receptor in PC12
cells emerged as a slowly migrating protein aggregate and a
high-molecular mass band with a calculated Rf value of almost
500 kDa (Fig. 1A). The addition of 0.1% SDS completely
dissociated these complexes, down to an 80- to 85-kDa dimeric-
like band (Fig. 1A). The dimeric complex, instead, was not
dissociated even in the presence of 2%SDS (data not shown). By
SDS-PAGE, the same endogenous P2Y4 receptor instead
appeared as a major dimeric-like 80–85 kDa protein and only
a minor 40–45 kDa band corresponding to the molecular mass
expected for the monomeric subunit, with a dimer/monomer
ratio of about 4/1 (Fig. 1A).
The endogenous P2Y6 receptor present in SH-SY5Y cells
instead appeared under BN-PAGE as a slowly migrating protein
aggregate, as a major complex with an Rf value of about
500 kDa, and a minor oligomer of about 230 kDa molecular
mass (Fig. 1B). A similar expression pattern under BN-con-
ditions was also observed for endogenous P2Y6 receptor present
in PC12 cells (data not shown). Differently from the P2Y4
receptor, a concentration of 1% SDS was necessary to dissociate
the higher aggregate and to highlight equal monomeric and
dimeric protein signals (Fig. 1B). By SDS-PAGE, the same
endogenous P2Y6 receptor instead appeared as two similarly
expressed protein bands with molecular masses corresponding
to both monomeric and dimeric forms (dimer/monomer ratio
∼1/1). Also when analysed in additional neuronal systems (rat
brain extract and primary cultures of cerebellar granule neurons)
under denaturing and reducing conditions of SDS-PAGE, the
P2Y4 receptor was always predominantly expressed as a dimer,
while the P2Y6 was equally distributed between monomeric and
dimeric forms (data not shown).The specificity of the signals raised in all the different
cellular systems by the P2Y4 and P2Y6 antisera was positively
verified by pre-adsorption of the antisera with each specific
antigen peptide (Fig. 1 and data not shown). Moreover, the
presence of all oligomeric signals was confirmed also by tran-
sient overexpression of Myc-P2Y4 and Myc-P2Y6 plasmids in
SH-SY5Y cells and detection of P2Y4 and P2Y6 receptors by
anti-Myc specific antibodies. In both cases, we found the entire
spectrum of proteins observed in the endogenous systems, with
molecular masses ranging from monomer to slowly migrating
aggregate (data not shown).
In synthesis, by BN-gel electrophoresis we provided expe-
rimental evidence that endogenous GPCRs such as P2Y4 and
P2Y6 expressed by several native neuronal phenotypes form
high order complexes, which might be the result of protein
homo- or hetero-interactions and /or lipid associations. Under
increasing denaturing conditions, the oligomers can be
disaggregated down to the predominant dimeric form of P2Y4
receptor, or to the dimeric and monomeric P2Y6 receptor.
Fig. 3. Hetero-dimerization of Myc-P2Y4 and FLAG-P2Y6 respectively with
FLAG-P2Y1,2,6,11 and Myc-P2Y1,2,4,11 receptors. SH-SY5Y cells were transiently
co-transfected with Myc-P2Y4 plus, respectively, FLAG-P2Y1,2,6,11, HDAC-1
proteins (A), or with FLAG-P2Y6 plus, respectively, Myc-P2Y1,2,4,11, Aurora B
Kinase proteins (B). In all cases proteins were immunoprecipitated with the anti-
FLAG antibody and immunoblotted with anti-Myc antiserum. Protein bands were
detected with secondary anti-rabbit antiserum by ECL chemiluminescence. The
right lane of each gel, markedwith *, represents in vitromix of protein lysates from
cells expressing individual tagged-receptors. Each single blot is representative of
three separate experiments.
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interactions
In order to test if oligomerization of both P2Y4 and P2Y6
receptors can be, at least in part, of homomeric nature, we used
Myc- and FLAG-P2Y4 or Myc- and FLAG-P2Y6 plasmids to be
expressed in SH-SY5Y cells. Cell lysis, immunoprecipitation
with anti-FLAG and western blotting with anti-c-Myc antisera
were then performed. When the Myc- or FLAG-plasmids for
both P2Y4 and P2Y6 receptors were singularly transfected, im-
munoreactivity was obtained only for immunoglobulin light
chain (IgL) (Fig. 2). Conversely, by double cotransfection of
Myc- and FLAG-tagged plasmids for both P2Y4 and P2Y6
proteins, specific receptor immunoreactivity was raised in both
cases by anti-Tag antibodies. P2Y4 receptor appeared as 50 kDa
and 100 kDa protein bands, while P2Y6 receptor was identified
as a single monomeric band (the molecular masses higher than
endogenous proteins are given by the Myc-tag). Most impor-
tantly, immunoreactivity was not produced when cell lysates
singularly expressing either the Myc- or the FLAG-tagged
receptors were combined in vitro after cell lysis (Fig. 2). From
these results, we conclude that specific P2Y4 and P2Y6 protein
homo-interactions occur in intact cells and are not artefacts due
to antisera cross-reactions or protein detergent extraction during
cell lysis.
3.3. P2Y4 and P2Y6 recombinant receptors form heteromeric
complexes with additional P2Y receptors
Having assessed the propensity of both P2Y4 and P2Y6
receptors to homo-oligomerize in intact cells, we next inves-
tigated whether they could also form hetero-dimers. We em-Fig. 2. Homo-dimerization of differently tagged-P2Y4 and P2Y6 receptors. SH-
SY5Y cells were transfected with single plasmids encoding for Myc-P2Y4,
FLAG-P2Y4, Myc-P2Y6, FLAG-P2Y6 or with a combination of both tagged
forms of each receptor subunit (cotransfection). Solubilized proteins were
immunoprecipitated with the anti-FLAG resin and detected by western blot with
the anti-c-Myc antiserum. Protein bands were detected with secondary anti-
rabbit antiserum by ECL chemiluminescence. The first lane of each blot (mix)
derives from in vitro mixing (prior to immunoprecipitation) of protein lysates
from cells expressing individual tagged-receptors. IgL (Immunoglobulin light
chain) represents an unspecific immunoreaction obtained in all immunopreci-
pitated samples. Each blot is representative of four independent experiments.ployed the direct method of double cotransfection of either
Myc-/FLAG-P2Y4 or Myc-/FLAG-P2Y6 receptor plasmids,
respectively with all FLAG-/Myc-P2Y1,2,4,6,11 DNAs. After cell
lysis, immunoprecipitationwith anti-FLAG andwestern blotting
with anti-c-Myc antisera were performed in all cases, giving rise
either to an expected 50 kDa band when Myc-P2Y4 (Fig. 3A) or
Myc-P2Y6 (data not shown) were co-transfected with all FLAG-
P2Y plasmids, or different molecular mass bands according to
each specific receptor subtype, when FLAG-P2Y6 (Fig. 3B) or
FLAG-P2Y4 (data not shown) were co-transfected with all Myc-
P2Y plasmids. The exclusive presence of monomeric signals is
probably due to the fact that cells have a limited capacity to fully
reconstitute the oligomeric overexpressed receptor. The pre-
sence of positive signals detected in all the different receptor
combinations, thus established the feasibility of multiple P2Y
heteromeric interactions occurring in intact cells (immunoreac-
tivity was never obtained after in vitro mixing of the single Myc-
or FLAG-tagged lysates, Fig. 3 lanes labeled with *). Moreover,
the co-expression of both Myc- and FLAG-P2Y4/P2Y6 re-
ceptors with two unrelated proteins, FLAG- histone deacetylase-
1 (HDAC-1) and Myc-Aurora B kinase, did not raise positive
signals (Fig. 3), therefore reinforcing the specificity of all P2Y4
receptor interactions. These results thus signify that P2Y4 and
P2Y6 subunits posses the appropriate domains to interact with all
P2Y1,2,4,6,11 receptors.
Fig. 5. Selective presence of P2Y4 receptor dimer and P2Y6 receptor monomer
in lipid rafts from cerebellar synaptosomes. Triton-extracts from rat cerebellar
synaptosomes were separated by centrifugation on a sucrose gradient, as
described in Materials and methods. Aliquots of the gradient fractions (4 to 15)
and pellets were subjected to SDS-PAGE, western blot and immunolabeling
with anti-P2Y4, anti-P2Y6, anti-flotillin, anti-transferrin receptor (TfR) antisera,
anti-syntaxin1, anti-SNAP-25 and anti-VAMP-2/synptobrevin antibodies or
were spotted directly onto nitrocellulose membranes (dot blot, db) and probed
with peroxidase-coupled cholera toxin subunit B, in order to detect GM1.
Finally, filters were analysed by ECL chemiluminescence. Each single blot is
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between P2Y4 and P2Y6 receptors in naive PC12 cells
With the aim to establish the actual pattern of interactions
effectively occurring among P2Y proteins in a non-transfected
system, we examined P2Y4 and P2Y6 receptor hetero-oligo-
merization in naive PC12 cells which are endowed only with
P2Y2, P2Y4 and P2Y6 subunits [20,21]. As shown in Fig. 4, we
found the presence of the P2Y4 receptor (in the dimeric form)
only in the protein fraction immunoprecipitated by the P2Y6
antisera. Co-immunoprecipitation between P2Y4 and P2Y2 or
P2Y6 and P2Y2 receptors did not raise any positive signal (Fig.
4), therefore indicating that in PC12 cells the endogenous P2Y4
receptor forms hetero-oligomers only with the P2Y6 subunit.
This phenomenon moreover appears to be cell type specific, as
SH-SY5Y cells do not elicit any evident heteromeric oligomer-
ization at least among P2Y1, P2Y2, P2Y4 and P2Y6 receptors
(data not shown).
3.5. Differential distribution of P2Y4 and P2Y6 receptors in
lipid rafts of cerebellar synaptosomes
We next examined the distribution of the P2Y4 and P2Y6
receptor oligomers in specialized submembrane compartments,
such as synaptomes purified from rat cerebellar tissue and
separated on sucrose gradient. Both P2Y4 and P2Y6 receptors
were present as monomer, dimer and traces of oligomer in the
transferrin receptor containing high-density fractions, devoid of
lipid rafts (fraction 13–15) (Fig. 5). By decreasing the sucrose
density, we instead observed that whereas the P2Y4 subunit was
detected as a unique dimeric molecular form, the P2Y6 receptor
appeared as a monomeric protein (fractions 6–9, with a peak in
fraction 8, Fig. 5). It should be noted that these same low-
density sucrose fractions also contained flotillin and GM1 (Fig.Fig. 4. Selective hetero-oligomerization between P2Y4 and P2Y6 receptors in
naive PC12 cells. Protein lysates extracted from PC12 cells were pulled down
with anti-P2Y6 or anti-P2Y2 antisera, conjugated to True Blot™ anti-rabbit Ig IP
Beads. Immunoadsorbents were subjected to 10% polyacrylamide SDS-PAGE,
western blot and were immunostained with anti-P2Y2, P2Y4, or P2Y6 antisera,
as indicated. Protein bands were detected by ECL chemiluminescence with
HRP-conjugated rabbit IgG True Blot™. Each single blot is representative of
three separate experiments.
representative of two independent experiments.5), selective markers for lipid rafts, whereas synaptosomal
protein markers such as syntaxin1, SNAP-25 and VAMP-2/
synaptobrevin were present both in total and lipid rafts enriched
synaptosomal fractions. Our data therefore suggest that the
dimeric P2Y4 and the monomeric P2Y6 proteins display a
selective microdomain distribution in lipid rafts from specia-
lized cellular compartments such as synaptosomes. On the con-
trary, none of these receptors are enriched in lipid rafts fractions
of total cerebellar extracts and PC12 cells (data not shown).
3.6. Ligand activation modifies the oligomerization of P2Y6 but
not of P2Y4 receptor
We finally tested the effect of ligand activation on the qua-
ternary structure of P2Y4 and P2Y6 receptors. To this purposewe
utilized UTP, which is the only pyrimidine nucleotide phy-
siologically released from cells in concentrations suitable for
P2Y4 and P2Y6 receptor activation [22]. Whereas the distribu-
tion between monomeric and dimeric P2Y4 or P2Y6 receptors
was not apparently modulated by 100 μMUTP for up to 30 min
Fig. 6. Stabilization by extracellular UTP of the high oligomeric form of P2Y6
endogenous receptor expressed by SH-SY5Y cells. PC12 or SH-SY5Y cells
kept in complete culture medium were incubated for 0, 1 and 15 min with
100 μM UTP, lysed for BN electrophoresis and incubated for 1 h at 37 °C with
0.1% SDS. Samples were resolved with 12 or 8% gels, blotted, probed with anti-
P2Y4 or anti-P2Y6 antiserum and finally visualized by ECL chemiluminescence.
Each blot is representative of three independent experiments.
1597N. D’Ambrosi et al. / Biochimica et Biophysica Acta 1768 (2007) 1592–1599as analysed by SDS-PAGE and western blotting (data not
shown), the more native condition of BN gel electrophoresis was
sufficient to visualize a shift in oligomerization induced by UTP.
Both higher oligomeric forms (500 and 230 kDa bands) of P2Y6,
but not P2Y4 receptor were transiently modulated. In particular,
the addition of 100 μM UTP for 1 min stabilized only the
500 kDa form of both endogenous receptor expressed in SH-
SY5Y cells (Fig. 6) and PC12 cells (data not shown) and Myc-
fused P2Y6 complex (data not shown), with consequent loss of
the faster-migrating 230 kDa molecular mass aggregate. A pro-
longed treatment with UTP then restored the constitutive dis-
tribution of the P2Y6 oligomers.
4. Discussion
The main findings presented in this investigation are that: a)
in native cells of neuronal origin the GPCRs P2Y4 and P2Y6
proteins exist predominantly as homo- and/or hetero-oligomers
differently modulated by ligand activation; b) the protomeric
unit appears to be the monomer for P2Y6 and the dimer for the
P2Y4 subtype; c) the protomers are differentially enriched in
specialized membrane microdomains such as lipid rafts from
cerebellar synaptosomes. Altogether, these results would sup-
port the concept that quaternary structure also distinguishes
P2Y4 from P2Y6 receptor and this might be crucial for their
biological functions.
Several authors just speculated on possible oligomeric forms
particularly of P2Y4 and P2Y6 receptors simply by the ap-
pearance in SDS-PAGE of protein bands with molecular masses
higher than expected from aminoacid sequences [23,24]. In our
previous work, we proved as well that P2Y4 receptor exists
under multiple aggregation states, which are partially sustained
by disulphide bonds [13]. Nevertheless, evidence for the exis-
tence of GPCR oligomeric species using denaturing conditions
especially with transfected proteins suffers of several criticisms,
because of technical artefacts. This is the reason why, in the
present work, we addressed the question of receptor oligomeri-
zation using principally non-denaturing protein separation tech-niques applied to the analysis of endogenous proteins. We thus
proved that P2Y4 receptor is mostly expressed as a macro-
molecular complex disaggregated to a dimeric form by low
detergent concentration. The dimeric receptor is neither an
artefact due to detergent extraction (being present after hypo-
tonic cell lysis), nor a hyperglycosilation product (being insen-
sitive to glycosidase enzymatic activities) (data not shown).
Moreover, it is very stable, being preserved in spite of ionic
strength of the detergents used for cell lysis (deoxycholic acid,
sodium cholate, Triton X-100, DM, digitonin, data not shown),
and of denaturing and reducing gel conditions. The P2Y4 re-
ceptor dimer is also the only form associated with P2Y6 receptor
in naive PC12 cells, and present in low-density sucrose fractions
of lipid rafts from cerebellar synaptosomes. It finally represents
a conspicuous signal also in receptor-transfected SH-SY5Y
cells, as the most abundant monomer might simply result from a
saturated capacity of the cells to fully reconstitute the
overexpressed receptor. These results strongly suggest that the
basic unit of the P2Y4 receptor might be a dimer. As emerged
from a similar set of experiments, this is apparently not con-
firmed for the P2Y6 receptor whose basic unit can be instead
dissected down to the monomer. We believe that these features
would certainly condition the topological distribution of P2Y4
and P2Y6 receptors into the cell membrane and their consequent
functional outcome. For instance, they might contribute to ex-
plain the diverse desensitisation and internalisation properties
exhibited by P2Y4 and P2Y6 receptors after agonist activation.
It is well known that, among GPCRs, P2Y receptors can form
interactions of dual nature: homomeric within the same receptor
subunits, such as P2Y2 and P2Y12 [11,12], and heteromeric with
unrelated types of receptors, for instance with purinergic P1 [9]
and NMDA receptors [25]. We now proved that particularly the
P2Y4 and P2Y6 subunits are capable to participate to a third type
of interaction, the heteromeric association within the same
subfamily of P2Y receptors. Despite caveats must be applied in
the physiological impact of results obtained with transfected
proteins (showing that all possible combinations of receptor
coupling can indeed occur in SH-SY5Y cells), our results clearly
prove that all P2Y1,2,4,6,11 receptors do possess the specific
domains involved in oligomerization. Nevertheless, in the naive
system of PC12 cells endowed only with P2Y2, P2Y4 and P2Y6
receptor subunits, specific oligomerization takes place exclu-
sively between P2Y4 and P2Y6 subtypes. This does not rule out
that additional physiological interactions can instead occur in
other cell phenotypes and/or extracellular environments. This
mechanism certainly contributes to generate further structural
and functional heterogeneity among P2 receptors, therefore
providing evidence to help explain how different cells are able to
evoke diverse or even opposite responses in different tissues
upon the exposure to the same specific ligand [7,15].
It is lately emerging that the recurrent multiplicity of inter-
actions among GPCRs is also based on several connection
interfaces, often characterised by differently resistant molecular
binding types that stabilize the structure of the receptor com-
plexes [26,27]. This might explain why even a substantial
number of studies have failed to show unequivocal effects on
the dimer/oligomer ratio by specific agonists [28], which would
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of single molecules within the receptor complex [29]. This can
probably apply also to the P2Y4 receptor, as we could not find
any modification on the monomer/dimer/oligomer ratio by the
agonist UTP. Neither Kotevic and colleagues [11] demonstrat-
ing that P2Y2 receptors might form homo-complexes by fluore-
scence resonance energy transfer found any change in quater-
nary structure of P2Y2 by UTP. On the contrary, Savi and
co-authors reported that the antagonist Clopidogrel can modify
the P2Y12 receptor oligomerization [12], and here we showed
that the P2Y6 receptor complex is instead susceptible to agonist
conformational change, when detected by BN-PAGE analysis.
In both cases, the overall effect is to stabilize the high order
complex in the presence of the agonist (in our case), or dis-
aggregate it with the antagonist (Savi and co-authors), thus
suggesting that the active form of these native receptors might
indeed be the oligomer. Moreover, with our study we pointed
out that oligomeric stabilization by UTP is very rapid, being
detected within 1 min, and has a transient course. This trend
finely correlates with the rapid agonist-promoted kinetic of
inositol phosphate accumulation exhibited by P2Y6 receptor
[16], which could even be preceded, if not triggered, by the
same quaternary structure modification induced by ligand bin-
ding. Nevertheless, whether and how the ligands alter GPCR
dimerization is still an open and widely debated issue.
It is well known that, even if GPCRs, G-proteins and effector
enzymes are expressed at relatively low concentration in mam-
malian cells, they often are “pre-arranged” or “selectively com-
partmentalized” as a package on specialized cell membranes, to
provide sufficient enrichment and achieve rapid high-fidelity
signalling responses [30], a universal mechanism for increasing
effective concentration, restricting movements and favouring
direct molecular interactions [31]. The possibility that the dif-
ferent oligomerization states of P2Y4 and P2Y6 receptors could
lead to a different localization in specific sub-membrane com-
partments aiming to a different function was also analysed. The
P2Y4 and P2Y6 receptors both expressed in lipid rafts purified
from cerebellar synaptosomes apparently followed this pattern.
In fact, only the dimeric P2Y4 or the monomeric P2Y6 proteins
were found enriched in these compartments, signifying that the
diverse distribution of distinct protomers might be a functional
peculiarity of each receptor subtype. Sustaining the concept of
“receptosome” [32], it is then possible that these protomers
might be assembled into a larger complex, as shown from BN-
PAGE for both P2Y4 and P2Y6 receptors. This is in agreement
with the evidence that GPCRs indeed associate with hetero-
trimeric G-proteins, but also with a wide range of additional
transmembrane or soluble proteins [32] and lipids. It is well
known, for instance, that GPCRs can directly modulate ion
channels with mechanisms that involve the association between
receptors, as in the case of β2-adrenergic receptor and L-type
calcium channel [33]. Under this regard, the P2Y4 receptor is
already known to couple with neuronal calcium and potassium
channels [34], and to constitutively co-immunoprecipitate with
NMDA-1 receptor in CGN [25]. The P2Y6 receptor instead was
shown to interact at a still unknown level with lipopolysac-
charide and tumour necrosis factor α tyrosine kinase receptors[35,36]. For these reasons, in addition to the above-mentioned
receptors and other membrane or cytosolic proteins, we can
speculate that P2Y4 and P2Y6 “receptosome” might even com-
prise several P2Y subtypes, as we have shown here. This par-
ticular issue would be the subject of further investigations.
In conclusion, here we established that within the same sub-
family of GPCRs, the quaternary structure of two close recep-
tors such as P2Y4 and P2Y6 still presents different features,
which might aim to specific functional regulation and mem-
brane partitioning. Given the concomitant multiple expression
of different purinergic subtypes on most mammalian cells, here
we uncovered a novel molecular complexity and dynamic ar-
chitecture of P2Y4 and P2Y6 proteins. This sustains the concept
of “combinatorial receptor web” which has been introduced for
these receptors to explain their increasing diversities in agonist
and antagonist selectivity, transmission signaling, and func-
tional properties [37].
As P2 receptors are becoming important therapeutic targets
for numerous diseases, our results would also open a new venue
in the design of novel multi-receptor targeted drugs to go along
with single-receptor selective substances.
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